Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cronos Group Inc.

Cronos Group Inc. (CRON) Stock Overview

Explore Cronos Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

CRON●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$3.16
$0.08(2.64%)
U.S. Market is Open · 14:50

Cronos Group Inc. (CRON)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio17.48
EPS (TTM)$0.11
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$3.33
3 Months$3.34
1 Year Target$3.15

CRON Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cronos Group Inc. (NASDAQ: CRON) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Cronos Group Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CRON on the NASDAQ shows an RSI of 67.95, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.15 for the NASDAQ listing.

Key metrics behind Cronos Group Inc.'s NASDAQ-traded stock include a P/E ratio of 17.48 and a market capitalization of 1.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CRON on the NASDAQ.

Price Performance (NASDAQ: CRON)

1-Day Change
2.92%
5-Day Change
1.28%
1-Month Change
15.27%
3-Month Change
14.44%
6-Month Change
23.35%
Year-to-Date (YTD) Change
20.53%
1-Year Change
23.83%
3-Year Change
83.24%
5-Year Change
-52.26%
All-Time (Max) Change
1821.21%

Contact Information

https://www.thecronosgroup.com
14165040004
111 Peter Street, Stayner, ON, M5V 2H1

Company Facts

6,100 Employees
IPO DateFeb 27, 2018
CountryCA
Actively Trading

Frequently Asked Questions